Mustafa Doğan,
Elif Ertan
Neovascular age-related macular degeneration: 18-month outcomes of aflibercept treatment in patients resistant to ranibizumab
Neovascular age-related macular degeneration: 18-month outcomes of aflibercept treatment in patients resistant to ranibizumab
The European Research Journal
2019-Cilt: 5 - Sayı: 6
977-980
46
68